University of Massachusetts Medical School

Worcester, MA

Sorting 3 by

Accepting patients

DREAMM-10

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Belantamab Mafodotin, Lenalidomide and Dexamethasone Versus Daratumumab, Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma who are Ineligible for Autologous Stem Cell Transplant
Learn more
  • Antibody Drug Conjugate (ADC)
  • BCMA
  • Phase 3

Accepting patients

EXCALIBER - Maintenance

Phase 3 Clinical Trial Comparing Iberdomide VS Lenalidomide as Maintenance Therapy Following Autologous Stem Cell Transplant in Participants with Newly Diagnosed Multiple Myeloma
Learn more
  • CELMoD
  • Randomization
  • Post-Autologous Stem Cell Transplant
  • Phase 3

Not yet accepting

MagnetisMM-30

A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma
Learn more
  • Bispecific T Cell Engager (BiTE)
  • Bispecific Antibody
  • BCMA
  • CD3
  • Phase 1
  • Has results
1 hidden based on your filters.Show All